EVENT DESCRIPTION: This presentation will describe the advantages of technology for the prevention and treatment of substance use in the perinatal period, review examples and findings from existing programs, and facilitate discussion of how technology might address other needs in attendees’ communities. 

• Dr. Steven Ondersma is C.S. Mott Endowed Professor of Public Health in the Charles Stewart Mott Department of Public Health at Michigan State University, and Director of the e-Health in Pregnancy (e-HELP) Lab. His primary interest is in population-level interventions promoting maternal and child health in underserved communities, particularly via technology-based brief interventions in the perinatal period. He is a Fellow of the American Psychological Association (Division 37), former Editor of the journal Child Maltreatment, a member of the Motivational Interviewing Network of Trainers, and currently serves on the Board of Scientific Counselors for the CDC’s National Center for Injury Prevention and Control. He previously co-chaired the Neonatal Opioid Withdrawal Syndrome subgroup of the NIH’s Environmental Influences on Child Health Outcomes (ECHO) initiative. He has led multiple NIH and CDC-funded studies focusing on the development, validation, and implementation of novel screening techniques and digital interventions in healthcare settings. Dr. Ondersma is also leading development of the Computerized Intervention Authoring System (CIAS 3.0), an NIH-funded, non-commercial, open research resource facilitating development of interactive and sophisticated digital interventions for any platform without coding (available at www.cias.app). Applied uses of CIAS 3.0 include community-directed direct development of digital interventions through hackathon-style “Appathons” and a program integrating digital screening, feedback, and facilitation of service receipt into prenatal care clinics statewide (www.ht-2.org).
• Dr. Amy Loree, HFHS